In renal failure, IV anesthetic used
**Core Concept**
In patients with renal failure, the choice of intravenous (IV) anesthetic agent is crucial due to the risk of accumulation and toxicity of certain drugs. The kidneys play a vital role in eliminating many anesthetic agents, and impaired renal function can lead to their accumulation, increasing the risk of adverse effects.
**Why the Correct Answer is Right**
Propofol is a commonly used IV anesthetic agent in patients with renal failure. It is metabolized by the liver and has a short half-life, which reduces the risk of accumulation and toxicity. Propofol does not require dosage adjustment in patients with renal failure, making it a safer choice. Additionally, propofol has a rapid onset and offset of action, allowing for easy titration and minimizing the risk of prolonged sedation.
**Why Each Wrong Option is Incorrect**
**Option A:** **Barbiturates**, such as thiopental, are not suitable for patients with renal failure due to their long half-life and potential for accumulation, leading to toxicity.
**Option B:** **Opioids**, such as fentanyl, can be used in patients with renal failure but require careful dosing and monitoring due to their potential for accumulation and respiratory depression.
**Option C:** **Etomidate** is not the best choice for patients with renal failure due to its potential for adrenal suppression and its interaction with the renin-angiotensin-aldosterone system.
**Clinical Pearl / High-Yield Fact**
In patients with renal failure, always consider the pharmacokinetics and pharmacodynamics of the anesthetic agent, and choose drugs with a short half-life and minimal accumulation potential.
**Correct Answer:** C. Etomidate